Skip to main content

Pharmacy

By Jeff Lagasse | 03:07 pm | July 30, 2021
Only 16 drugs approved through the pathway have ever been withdrawn, and in some cases the confirmatory trials were never done.
By Jeff Lagasse | 11:35 am | July 30, 2021
The projected average basic premium is calculated based on plans' expectations of per capita drug spending in the coming year.
By Susan Morse | 10:31 am | July 29, 2021
Vaccination immunity may wane and, a dose given six months after the second shot boosts antibodies against the Delta variant, Pfizer says.
By Jeff Lagasse | 12:12 pm | July 14, 2021
Medicaid will see increased costs through beneficiaries' direct payment of the drug, plus potentially higher Medicare premium payments.
By Jeff Lagasse | 01:15 pm | July 13, 2021
The analysis will target aducanumab, recently approved by the FDA, as well as any future monoclonal antibodies that treat Alzheimer's.
By Susan Morse | 06:09 pm | July 12, 2021
Vaccine Adverse Event Reporting data shows 95 hospitalizations and one reported death, out of 12.5 million doses administered.
By Susan Morse | 04:14 pm | July 09, 2021
FTC and DOJ officials say they will soon update their merger guidelines.
By Jeff Lagasse | 12:24 pm | July 09, 2021
Pharmaceutical companies raised compensation for their top executives while steadily increasing drug prices, the committee found.
By Susan Morse | 10:46 am | July 08, 2021
The strategic partnership is on track to open at least 600 primary care practices in more than 30 U.S. markets over the next four years.
By Susan Morse | 01:12 pm | July 07, 2021
Hospitals realized a 30% cut in reimbursement after an appeals court ruling upheld the Trump Administration decision.